Levonoorgestrel enteric-coated tablets, enteric-coated tablets emergency remedy contraceptive brand, focusing on the research and development, production and sales of reproductive health drugs, chronic disease drugs, and external drugs
Guangzhou Langsheng Pharmaceutical Co., Ltd. (Regenex or Regenex) is a high-tech pharmaceutical enterprise focusing on R&D, production and sales in the fields of reproductive health drugs, chronic disease drugs and external drugs.Founded in 2003, the company is located in Guangzhou Science City, a famous high-tech industrial park in China, with beautiful scenery, and was founded by Dr. Lu Zhijun, a returnee from the United States. The factory has a construction area of 26,362 square meters and more than 500 employees, including more than 250 marketing personnel and more than 40 R&D personnel.
The company listed in 2008 in the field of birth control with independent intellectual property rights of "Danmei" (levonorgestrel enteric-coated tablets) has passed the new GMP certification in 2010, and the product has won the title of "Guangzhou Famous Trademark".
The company's marketing center adheres to the concept of "customer first, full marketing", and establishes an effective and innovative new business model of marketing, promotion and brand coordinated development in the Chinese pharmaceutical market with an enterprising attitude, implements GPS trajectory management for marketing personnel, implements terminal standard play for marketing, and implements 7×16-hour high-quality customer service follow-up with professional background after sales. At present, the marketing center has cultivated nearly 100 senior regional managers and market managers, as well as nearly 500 professional marketing, promotion and marketing personnel, and has established partnerships with more than 150 dealers across the country, and the sales network covers the whole of China.
The company's R&D center adheres to the R&D strategy of "source system and system innovation", takes new drug research and development as the goal, takes drug research and development in the field of reproductive health as the main direction, integrates information, scientific research and pilot test, and currently has 40 new drug projects under development. It has undertaken more than 20 national, provincial and municipal scientific and technological projects, and applied for 20 invention patents (1 US patent), of which 10 have been authorized. The R&D center has successfully built technical platforms such as chiral drug synthesis, injection long-acting liposome targeted drug delivery system, oral sustained-release drug delivery system, insoluble drug immediate-release system, and rapid analysis of complex systems, and has achieved domestic leading technical advantages in reproductive health, elderly health, high-end latex products, nutrition and health care and other subdivisions, and the comprehensive strength of new drug research and development has ranked at the leading level in South China.
Langsheng Pharmaceutical adheres to the corporate mission of "making human reproduction healthier", practices the corporate culture of "value, efficiency and pleasure", and advocates the value concept that personal value is reflected in the process of realizing corporate value and customer value. In the future development process, the company will continue to develop high-tech products, expand business areas, and realize the company's take-off again.
